| pubmed-article:11427427 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0035924 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0740178 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0040557 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0020980 | lld:lifeskim |
| pubmed-article:11427427 | lifeskim:mentions | umls-concept:C0680536 | lld:lifeskim |
| pubmed-article:11427427 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11427427 | pubmed:dateCreated | 2001-6-27 | lld:pubmed |
| pubmed-article:11427427 | pubmed:abstractText | A comparative evaluation of the Abbott AxSYM and DPC Immulite random-access analyzers was performed using 497 prospectively collected serum samples. These samples were sent to the laboratory for routine antenatal screening for hepatitis B surface antigen and immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement between the two assay systems ranged from 97.4 to 100%. After discrepancy analysis, the outcome in terms of sensitivity and specificity varied from 98.2 to 100% for all but one of the assays tested. The AxSYM rubella virus IgG assay tended to report protective or indeterminate antibody levels in 1% of the samples. This shortcoming might be overcome by raising the cutoff of the microparticle enzyme immunoassay system. | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11427427 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11427427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11427427 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11427427 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:11427427 | pubmed:issn | 1071-412X | lld:pubmed |
| pubmed-article:11427427 | pubmed:author | pubmed-author:VlaspolderFF | lld:pubmed |
| pubmed-article:11427427 | pubmed:author | pubmed-author:DieperslootR... | lld:pubmed |
| pubmed-article:11427427 | pubmed:author | pubmed-author:Dunnewold-Hoe... | lld:pubmed |
| pubmed-article:11427427 | pubmed:author | pubmed-author:Kruit-Den... | lld:pubmed |
| pubmed-article:11427427 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11427427 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:11427427 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11427427 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11427427 | pubmed:pagination | 785-7 | lld:pubmed |
| pubmed-article:11427427 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:meshHeading | pubmed-meshheading:11427427... | lld:pubmed |
| pubmed-article:11427427 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11427427 | pubmed:articleTitle | Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems. | lld:pubmed |
| pubmed-article:11427427 | pubmed:affiliation | Laboratory for Medical Microbiology, Diakonessen Hospital, Utrecht, The Netherlands. Rdiepersloot@diakhuis.nl | lld:pubmed |
| pubmed-article:11427427 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11427427 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11427427 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11427427 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11427427 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11427427 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11427427 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11427427 | lld:pubmed |
